What's new

Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 26, Status: Authorised

May 23, 2025 - 14:55
 0
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

STAT+: Pharmalittle: We’re reading about Trump’s drug-pricing claims, FDA’s Covi...

Next Article

Human medicines European public assessment report (EPAR): Inhixa, enoxaparin sod...

Related Posts

Nitrosamines EMEA-H-A5(3)-1490 - Questions and answers ...

May 19, 2025  0

Medicinal products for human use: monthly figures - Apr...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 17, 2025  0